secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K/A
Filed at:   2023-12-22T23:59:59+00:00
Accession:  0001683168-23-009061
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical sets compensation for Frakes as Interim CEO ($500K salary) and Cipriani as COO ($390K)
--------------------------------------------------------------------------------

- James Frakes appointed Interim CEO effective Nov 7, 2023; base salary raised from $360K to $500K while in role.
- Guy Cipriani appointed SVP & COO effective Nov 7, 2023; base salary set at $390K; resigned from Board.
- Frakes also remains CFO and joined Board; salary may revert upon hiring of permanent CEO.
- Cipriani resigns from Board per terms; reports to Interim CEO then to new CEO when appointed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/aethlon_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-009061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer